Lattice Semiconductor is set to acquire technology company AMI for $1 billion in cash and around $650 million in shares. Georgia-based AMI is majority-owned by THL Partners, a middle-market private ...
May 4 (Reuters) - Lattice Semiconductor (LSCC.O), opens new tab will acquire AMI in a $1.65 billion deal, it said on Monday, as the chipmaker looks to expand into the software and artificial ...
Financing extension led by 8VC to advance LTS-201 as a potential significant commercial opportunity in Huntington’s disease (IND expected in 3Q 2026) Potential clinical proof-of-concept of Latus ...
PHILADELPHIA & BOSTON, May 04, 2026--(BUSINESS WIRE)--Latus Bio, Inc. (Latus), a biotechnology company engineering scalable gene therapies for broader patient populations, today announced the closing ...
Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...
Latus founder Beverly Davidson, Ph.D., awarded the ASGCT Outstanding Achievement Award – the Society’s highest honor Latus Bio, Inc. (Latus), a company advancing scalable genetic medicines for broad ...
Physicists have spent the last 20 years pondering an apparent discrepancy between experimental results and theoretical predictions for the magnetic properties of the muon, the electron’s heavier ...
Quantum computing holds transformative potential for simulating nonlinear physical systems, such as fluid turbulence. However, mapping nonlinear dynamics to the linear operations required by quantum ...
Optical lattice clocks are emerging timekeeping devices based on tens of thousands of ultracold atoms trapped in an optical lattice (i.e., a grid of laser light). By oscillating between two distinct ...
PHILADELPHIA--(BUSINESS WIRE)--Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in AAV gene therapy, has announced new research published today in Science Translational Medicine, ...
PHILADELPHIA--(BUSINESS WIRE)--Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in AAV gene therapy, is pleased to announce data presentations in support of its preclinical drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results